key: cord-1050870-g1l47yky
authors: Kumar, Anil; Sathyapalan, Dipu; Ramachandran, Arya; Subhash, Kiran; Biswas, Lalitha; Beena, K.V.
title: SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India()
date: 2020-09-16
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.09.013
sha: af69dcd37bfea5a817e46014e2eed01a63931131
doc_id: 1050870
cord_uid: g1l47yky

nan

To the editor, COVID-19 pandemic is posing a severe challenge to the fragile health care system of low and middle-income countries like India. The state of Kerala was the first to report COVID-19 in India, on 30 th January 2020, in a medical student who had returned from Wuhan, China [1] .

The quantum of cases reported, even after five months, as on 14 th July 2020, is only 8,930

with 36 deaths. The "Kerala Model" of COVID-19 pandemic response was to trace, quarantine, test, isolate and treat all travellers from foreign countries as well as neighbouring states, coupled with the lockdown. We hypothesize that due to this, the state has succeeded in preventing community spread in the last five months. This is evidenced by the fact that there was no surge in hospital admissions due to influenza like illness (ILI) or COVID-19 clusters or outbreaks in occupational settings.

In the background of community transmission, there is always a high risk of transmission to the healthcare worker (HCW) from pre-symptomatic and asymptomatic patients reporting with non-COVID illness, especially in non-COVID-19 hospitals [2] . Identifying infected HCWs, including asymptomatic ones, is important to reduce nosocomial spread [2] .

Seroprevalence of SARS-CoV-2 antibodies in HCWs in non-COVID-19 hospitals can act as a surrogate marker for community transmission in the population catered by it. Our study aims to understand the prevalence of asymptomatic infection among HCWs in our university hospital to verify the existence of community transmission in the population.

Between 11 th and 24 th July 2020, health care workers of a 1200 bedded university teaching hospital, were recruited in this prospective, cross-sectional, mono-centric study. Ours being a non-COVID-19 hospital, all patients diagnosed with COVID-19 were transferred to the Fisher's exact test was used wherever applicable.

Overall 635 HCWs consented to participate in the study. All HCWs included in the study were asymptomatic at the time of enrolment. The various characteristics of the study population are summarized in table 1. Although SARS-CoV-2 IgG/total antibodies were detected in three HCWs, all of them were considered false positive due to low signal cut-off values All three positive cases were epidemiologically investigated to determine the validity of our results. A repeat serum sample after 14 days from the three HCWs (two positive only by Abbott IgG assay and one positive only be Roche assay) yielded the same results. Though all three were categorised as high risk, they denied any episode of ILI or contact with J o u r n a l P r e -p r o o f laboratory-confirmed COVD-19. RT-PCR of NP swab was also negative. Overall, the seroprevalence of SARS-CoV-2 antibody was found to be 0%.

Even after five months of reporting the first case of COVID-19, our study found no prevalence of the SARS-CoV-2 antibody in HCWs in our institution. This may be partly due to the "Kerala Model" of COVID-19 pandemic response which has also been acknowledged by WHO [3] . The robust implementation of infection control protocols and strict adherence to personal protective equipment guidelines evidenced by the high adherence rates (table 1) , also had a significant role to play in preventing infection in HCWs. Recent studies from highincome countries like the Germany, Italy, England and Belgium reported prevalence rates of 1.6%, 3.4%, 6% and 6.4% respectively [4] [5] [6] .

The main limitation of our study was that it was done in a single private centre, which was a designated non-COVID-19 hospital with manageable patient load, good infrastructure and robust infection control practices. The same may not be true in COVID-19 and non-COVID-19 public sector hospitals with large patient burden, limited staff, inadequate personal protective equipment and frequent breach in infection control practices. The data on adherence to infection control protocol is limited by the fact that, the staff might have felt pressured to say they were strictly adhering to it, in terms of PPE, even if they did not.

Another major limitation is the overall low prevalence of COVID-19 in the general population, as the epidemiological peak, in Kerala, is yet to be reached, leading to false positives in our serological assays which had specificities of <100%.The findings of our study should be considered an exception, as similar studies in other high burden India states, is sure to reveal higher seroprevalence.

J o u r n a l P r e -p r o o f 

What was right about Kerala's response to the COVID-19 pandemic?

CoV-2 infection in household contacts of a healthcare provider

World Health Organization. International Health Regulations

SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients

COVID-19 infections among Healthcare Workers in an Infectious Diseases specialized setting in Naples, Southern Italy: results of a cross-sectional surveillance study

SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England